The results demonstrate, for the first time, a strong association of low muscle mass and high tumor IL-6 expression with mortality, a finding that could eventually be useful in treatment and prognostication in ccRCC. This evidence concerns the gene IL6 and nonpapillary renal cell carcinoma.